The World Health Organization (WHO) today announced that it has issued an emergency use listing for India's Covaxin vaccine, clearing the way for its use in the COVAX program that is a key part of reaching immunization targets.The addition of another vaccine to the COVAX portfolio also comes as global cases are rising again, following several weeks of decline.WHO OKs 8th COVID vaccineCovaxin, developed by Bharat Biotech, is an inactivated vaccine given in two doses 4 weeks apart in adults.
It is the eighth vaccine given emergency use approval by the WHO.Clinical studies suggest the vaccine has 78% efficacy against any COVID-19 severity.